A randomized, multi-center, open-label, phase III study of once-per-cycle DA-3031, a pegylated G-CSF, in comparison with daily filgrastim in patients receiving TAC chemotherapy for breast cancer
Titel:
A randomized, multi-center, open-label, phase III study of once-per-cycle DA-3031, a pegylated G-CSF, in comparison with daily filgrastim in patients receiving TAC chemotherapy for breast cancer
Auteur:
Park, K. H. Lee, S. Park, J. H. Kang, S. Y. Kim, H. Y. Park, I. H. Park, Y. H. Im, Y. H. Lee, H. J. Park, S. Lee, S.I. Jung, K.H. Kim, Y.S. Seo, Jae Hong